Genomics & Genetics Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Covance reports Signet release of new monoclonal antibodies, acquisition of company's assets
July 14th, 2006
Signet Laboratories, Inc., a medical diagnostics and research company developing monoclonal antibodies and diagnostic assays for cancer, infectious disease, and neurodegenerative disease, announced the availability of two new monoclonal antibodies L1 clone 14.10 and PTEN clone 6H2.1, according to Covance Research Products. Covance also announced it has acquired substantially all of the assets of Signet Laboratories, Inc. Signet, which is based in Dedham, Massachusetts, is a provider of monoclonal antibodies used in the research of cancer, infectious disease, and neurodegenerative disease. The mouse monoclonal anti-L1 clone 14.10 released by Signet...
Source: Genomics & Genetics Weekly (2006-07-14)
|
